PT3634411T - Métodos para o tratamento de nash e para a prevenção de hcc induzido por nash - Google Patents

Métodos para o tratamento de nash e para a prevenção de hcc induzido por nash

Info

Publication number
PT3634411T
PT3634411T PT187399290T PT18739929T PT3634411T PT 3634411 T PT3634411 T PT 3634411T PT 187399290 T PT187399290 T PT 187399290T PT 18739929 T PT18739929 T PT 18739929T PT 3634411 T PT3634411 T PT 3634411T
Authority
PT
Portugal
Prior art keywords
nash
methods
preventing
treating
induced hcc
Prior art date
Application number
PT187399290T
Other languages
English (en)
Original Assignee
N Gene Res Laboratories Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by N Gene Res Laboratories Inc filed Critical N Gene Res Laboratories Inc
Publication of PT3634411T publication Critical patent/PT3634411T/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/4545—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring hetero atom, e.g. pipamperone, anabasine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/444—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring heteroatom, e.g. amrinone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2866—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against receptors for cytokines, lymphokines, interferons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
PT187399290T 2017-06-08 2018-06-08 Métodos para o tratamento de nash e para a prevenção de hcc induzido por nash PT3634411T (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201762516681P 2017-06-08 2017-06-08

Publications (1)

Publication Number Publication Date
PT3634411T true PT3634411T (pt) 2023-11-28

Family

ID=62875071

Family Applications (1)

Application Number Title Priority Date Filing Date
PT187399290T PT3634411T (pt) 2017-06-08 2018-06-08 Métodos para o tratamento de nash e para a prevenção de hcc induzido por nash

Country Status (13)

Country Link
US (1) US11357768B2 (pt)
EP (1) EP3634411B1 (pt)
JP (1) JP7270979B2 (pt)
KR (2) KR20240023698A (pt)
CN (1) CN110719780A (pt)
AU (2) AU2018282124B2 (pt)
DK (1) DK3634411T3 (pt)
ES (1) ES2966459T3 (pt)
FI (1) FI3634411T3 (pt)
HU (1) HUE064743T2 (pt)
PL (1) PL3634411T3 (pt)
PT (1) PT3634411T (pt)
WO (1) WO2018225026A1 (pt)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102965781B1 (ko) 2025-11-18 2026-05-20 주식회사 팜토리 과채류 포장 장치

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU9502843D0 (en) 1995-09-29 1995-11-28 Livigene Ltd Pharmaceutical composition
JP2004182638A (ja) 2002-12-03 2004-07-02 Yakult Honsha Co Ltd 炎症性疾患又は悪性腫瘍の予防治療剤
HUP0401177A2 (en) 2004-06-14 2007-09-28 N Gene Res Lab Inc Pharmaceutical composition for increasing the mitochondrial genesis
WO2009070781A1 (en) * 2007-11-30 2009-06-04 The Regents Of The University Of California Methods of treating non-alcoholic steatohepatitis (nash) using cysteamine products
RU2654231C2 (ru) 2011-06-28 2018-05-17 Алтернатив Инновейтив Текнолоджиз, Ллц Способ применения белков теплового шока-70 (бтш70) для повышения выносливости и лечения бтш70-зависимых заболеваний (варианты)
HUP1100444A2 (en) 2011-08-17 2013-02-28 Pharma Gene Sa Pharmaceutical composition

Also Published As

Publication number Publication date
WO2018225026A1 (en) 2018-12-13
JP2020523296A (ja) 2020-08-06
US11357768B2 (en) 2022-06-14
DK3634411T3 (da) 2023-12-04
KR20200013704A (ko) 2020-02-07
US20200179363A1 (en) 2020-06-11
KR102636934B1 (ko) 2024-02-16
RU2019144060A3 (pt) 2021-10-20
FI3634411T3 (fi) 2023-12-15
EP3634411A1 (en) 2020-04-15
JP7270979B2 (ja) 2023-05-11
RU2019144060A (ru) 2021-07-09
AU2024266953A1 (en) 2024-12-19
PL3634411T3 (pl) 2024-03-11
HUE064743T2 (hu) 2024-04-28
AU2018282124B2 (en) 2024-09-19
ES2966459T3 (es) 2024-04-22
CN110719780A (zh) 2020-01-21
AU2018282124A1 (en) 2020-01-02
KR20240023698A (ko) 2024-02-22
EP3634411B1 (en) 2023-09-20

Similar Documents

Publication Publication Date Title
IL267247B (en) Compositions and methods for treating cancer
ZA201907158B (en) Methods and compositions for treating sleep apnea
IL266053A (en) Preparations and methods for the treatment of ezh2-mediated cancer
IL260525B (en) Means and methods for treating the hepatitis virus (hbv)
PL3573617T3 (pl) Związki na bazie pirazolu do stosowania w leczeniu nash i marskości wątroby
IL274837A (en) Methods and preparations for the treatment of cancer
IL255929A (en) Preparations and methods for the treatment of cancer
IL251215A0 (en) Cannabinoid preparation and method for treating pain
IL262223A (en) Methods for monitoring and treating cancer
SG11201703064WA (en) Compositions and methods for treating insomnia
GB201710906D0 (en) Compounds and methods for treating peripheral neuropathy
IL325803A (en) Compositions and methods for treating cancer
ZA201807653B (en) New tetrahydropyrimidodiazepin and dihydropyridodiazepin compounds for treating pain and pain related conditions
IL255638A (en) Compositions and methods for treating cancer
IL271923A (en) Methods and compounds for the treatment of addictions
SG10202013112YA (en) Zinc-gamma-pga compositions and methods for treating cancer
GB2539474B (en) Glove and treatment method
IL272782A (en) Preparations and methods for the treatment of cancer
ZA202000407B (en) Device and method for treating must
ZA202002526B (en) New alcoxyamino derivatives for treating pain and pain related conditions
PL3634411T3 (pl) Sposób leczenia niealkoholowego stłuszczeniowego zapalenia wątroby (NASH) i zapobiegania indukowanemu NASH rakowi wątrobowokomórkowemu (HCC)
ZA201802268B (en) Methods and compositions for preventing or treating cancer
PL3272934T3 (pl) Wkład filtra i urządzenie do obróbki prania
GB201609402D0 (en) Materials and methods for treating cancer
ZA201904626B (en) Cancer treatment method and composition